HealthEquity (NASDAQ:HQY) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen cut shares of HealthEquity (NASDAQ:HQY) from a buy rating to a hold rating in a research report released on Saturday morning.

HQY has been the subject of a number of other research reports. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. Royal Bank Of Canada upped their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Citizens Jmp raised their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Finally, Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Stock Up 1.2%

NASDAQ HQY opened at $104.63 on Friday. HealthEquity has a 1 year low of $72.76 and a 1 year high of $106.42. The stock has a market capitalization of $8.75 billion, a PE ratio of 39.19, a PEG ratio of 1.76 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The business’s 50-day moving average is $93.37 and its 200 day moving average is $85.79.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The business’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts forecast that HealthEquity will post 3.92 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock worth $1,651,280 in the last three months. 1.60% of the stock is owned by corporate insiders.

Institutional Trading of HealthEquity

A number of hedge funds have recently made changes to their positions in the stock. Fifth Third Wealth Advisors LLC increased its position in HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after buying an additional 116 shares in the last quarter. Truist Financial Corp raised its stake in HealthEquity by 4.9% during the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after buying an additional 119 shares during the last quarter. Fiduciary Trust Co boosted its holdings in HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its holdings in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares in the last quarter. Finally, Merit Financial Group LLC grew its stake in shares of HealthEquity by 8.9% in the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after acquiring an additional 172 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.